tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DE:ANW Stock Latest News

Immuron Limited Showcases Promising Biopharmaceutical Innovations
Company AnnouncementsImmuron Limited Showcases Promising Biopharmaceutical Innovations
2d ago
Immuron Limited Secures Approval on Key AGM Resolutions
PremiumCompany Announcements
Immuron Limited Secures Approval on Key AGM Resolutions
5d ago
Immuron Limited Sees Record Sales and Positive Trial Developments
PremiumCompany Announcements
Immuron Limited Sees Record Sales and Positive Trial Developments
6d ago
Immuron Limited Director’s Option Expiry Update
PremiumCompany Announcements
Immuron Limited Director’s Option Expiry Update
10d ago
Immuron Limited Issues New Unquoted Performance Rights
PremiumCompany Announcements
Immuron Limited Issues New Unquoted Performance Rights
26d ago
Immuron Limited Schedules 2024 Annual General Meeting
PremiumCompany AnnouncementsImmuron Limited Schedules 2024 Annual General Meeting
1M ago
Immuron’s Innovative Antibody Solutions Highlighted at Healthcare Conference
Premium
Company Announcements
Immuron’s Innovative Antibody Solutions Highlighted at Healthcare Conference
1M ago
Immuron Limited Showcases Innovations at Healthcare Conference
Premium
Company Announcements
Immuron Limited Showcases Innovations at Healthcare Conference
1M ago
Immuron reports Q3 sales of Travelan up 13% vs. Q2
PremiumThe Fly
Immuron reports Q3 sales of Travelan up 13% vs. Q2
1M ago
IMRN
Immuron Limited’s Travelan Sales Surge Globally
PremiumCompany Announcements
Immuron Limited’s Travelan Sales Surge Globally
1M ago
Immuron Limited Announces New Securities Quotation
PremiumCompany Announcements
Immuron Limited Announces New Securities Quotation
2M ago
Immuron says NMRC completes interim analysis for evaluation in Campylobacter
PremiumThe Fly
Immuron says NMRC completes interim analysis for evaluation in Campylobacter
2M ago
IMRN
Immuron’s New Oral Therapeutic Shows Promise in NMRC Trial
PremiumCompany AnnouncementsImmuron’s New Oral Therapeutic Shows Promise in NMRC Trial
2M ago
Immuron trading halted, news pending
Premium
The Fly
Immuron trading halted, news pending
2M ago
IMRN
Immuron initiated with a Buy at Litchfield Hills
Premium
The Fly
Immuron initiated with a Buy at Litchfield Hills
2M ago
IMRN
Immuron Showcases Novel Immunotherapies at Conference
PremiumCompany Announcements
Immuron Showcases Novel Immunotherapies at Conference
2M ago
Immuron plans Phase 2 trial for IMM-529 following FDA review
PremiumThe Fly
Immuron plans Phase 2 trial for IMM-529 following FDA review
3M ago
IMRN
Immuron’s IMM-529 Eyes Phase 2 Trial for CDI Treatment
PremiumCompany Announcements
Immuron’s IMM-529 Eyes Phase 2 Trial for CDI Treatment
3M ago
Immuron Limited Sees Revenue Surge Amid Rising R&D Costs
PremiumCompany Announcements
Immuron Limited Sees Revenue Surge Amid Rising R&D Costs
3M ago
Immuron Limited CEO to Present at Biotech Event
PremiumCompany AnnouncementsImmuron Limited CEO to Present at Biotech Event
3M ago
Immuron announces new DoD research award for NMRC
Premium
The Fly
Immuron announces new DoD research award for NMRC
3M ago
IMRN
Immuron Secures US Defense Grant to Advance Travelan
Premium
Company Announcements
Immuron Secures US Defense Grant to Advance Travelan
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >